Importance of sentinel lymph node biopsy in patients with thin melanoma.

Journal Article (Journal Article)

HYPOTHESIS: The status of the sentinel node (SN) confers important prognostic information for patients with thin melanoma. DESIGN, SETTING, AND PATIENTS: We queried our melanoma database to identify patients undergoing sentinel lymph node biopsy for thin (< or =1.00-mm) cutaneous melanoma at a tertiary care cancer institute. Slides of tumor-positive SNs were reviewed by a melanoma pathologist to confirm nodal status and intranodal tumor burden, defined as isolated tumor cells, micrometastasis, or macrometastasis (< or =0.20, 0.21-2.00, or >2.00 mm, respectively). Nodal status was correlated with patient age and primary tumor depth (< or = 0.25, 0.26-0.50, 0.51-0.75, or 0.76-1.00 mm). Survival was determined by log-rank test. MAIN OUTCOME MEASURES: Disease-free and melanoma-specific survival. RESULTS: Of 1592 patients who underwent sentinel lymph node biopsy from 1991 to 2004, 631 (40%) had thin melanomas; 31 of the 631 patients (5%) had a tumor-positive SN. At a median follow-up of 57 months for the 631 patients, the mean (SD) 10-year rate of disease-free survival was 96% (1%) vs 54% (10%) for patients with tumor-negative vs tumor-positive SNs, respectively (P < .001); the mean (SD) 10-year rate of melanoma-specific survival was 98% (1%) vs 83% (8%), respectively (P < .001). Tumor-positive SNs were more common in patients aged 50 years and younger (P = .04). The SN status maintained importance on multivariate analysis for both disease-free survival (P < .001) and melanoma-specific survival (P < .001). CONCLUSIONS: The status of the SN is significantly linked to survival in patients with thin melanoma. Therefore, sentinel lymph node biopsy should be considered to obtain complete prognostic information.

Full Text

Duke Authors

Cited Authors

  • Wright, BE; Scheri, RP; Ye, X; Faries, MB; Turner, RR; Essner, R; Morton, DL

Published Date

  • September 2008

Published In

Volume / Issue

  • 143 / 9

Start / End Page

  • 892 - 899

PubMed ID

  • 18794428

Pubmed Central ID

  • PMC2561951

Electronic International Standard Serial Number (EISSN)

  • 1538-3644

Digital Object Identifier (DOI)

  • 10.1001/archsurg.143.9.892


  • eng

Conference Location

  • United States